Seth Rudnick, Director at Aralez Pharmaceuticals Inc. (ARLZ), bought 30,000 shares at $4.77 ($143K) on 2016-11-11, disclosed to the SEC on 2016-11-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| GTHX | SELL | 2020-12-23 | $1.3M | — | Filing → |
| GTHX | SELL | 2020-12-10 | $777K | — | Filing → |
| GTHX | SELL | 2020-12-03 | $10K | — | Filing → |